Urologix, Inc. (ULGX) Reports Q4 Loss of $0.08; Guides FY13 Sales

Urologix, Inc. (NASDAQ: ULGX) reported Q4 EPS of ($0.08), versus ($0.09) reported last year. Revenue for the quarter came in at $4.5 million, versus $2.92 million reported last year.

Urologix, Inc. sees FY2013 revenue of $17.5-19.0 million.

For earnings history and earnings-related data on Urologix, Inc. (ULGX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Stratasys (SSYS) Tops Q2 EPS by 2c ;; Offers Guidance
• Beyond Air, Inc. (XAIR) Tops Q1 reported Q1 Revenue ; Offers Guidance
• Nomad Foods Limited (NOMD) Tops Q2 EPS by 6c; offers guidance